Levemir FlexPen: Characteristics of the Insulin Product
Levemir FlexPen is an insulin product that is used for managing blood sugar levels in people living with diabetes. This insulin product is designed to be user-friendly and easy to use. In this article, we will discuss the characteristics of Levemir FlexPen, including the active substance, form, manufacturer, and how it works.
Active Substance of Levemir FlexPen
The active substance of Levemir FlexPen is insulin detemir. Insulin detemir is a synthetic insulin analog that is designed to mimic the action of natural insulin in the body. Insulin detemir works by binding to insulin receptors on cells in the body and allowing glucose to enter the cells, where it can be used as energy.
Form and Dosage of Levemir FlexPen
Levemir FlexPen is a pen-style device that contains insulin detemir. Each pen contains 300 IU of insulin detemir, which is equivalent to 3 mL of solution. The pen is designed for subcutaneous injection and comes with a disposable needle that is attached to the pen.
Levemir FlexPen is available in two different dosages: 100 units/mL and 200 units/mL. The 100 units/mL pen delivers insulin detemir in increments of 1 unit, while the 200 units/mL pen delivers insulin detemir in increments of 2 units. The recommended starting dose for Levemir FlexPen is based on the individual’s insulin requirements and should be determined by a healthcare professional.
Manufacturer of Levemir FlexPen
Levemir FlexPen is manufactured by Novo Nordisk, a global healthcare company that specializes in diabetes care. Novo Nordisk is committed to developing innovative diabetes products that help people living with diabetes manage their condition more effectively.
How Levemir FlexPen Works
Levemir FlexPen works by replacing the natural insulin that is produced by the pancreas. Insulin is a hormone that regulates blood sugar levels by allowing glucose to enter cells in the body where it can be used as energy. In people living with diabetes, the pancreas is unable to produce enough insulin, or the body is unable to use insulin effectively, resulting in high blood sugar levels.
When Levemir FlexPen is injected subcutaneously, it slowly releases insulin detemir into the bloodstream, allowing the insulin to control blood sugar levels over an extended period of time. Levemir FlexPen should be taken once or twice daily, depending on the individual’s insulin requirements.
In conclusion, Levemir FlexPen is an insulin product that is designed to help people living with diabetes manage their blood sugar levels. The active substance in Levemir FlexPen is insulin detemir, which mimics the action of natural insulin in the body. Levemir FlexPen is available in a pen-style device that is easy to use and comes with a disposable needle. The recommended starting dose and dosing frequency for Levemir FlexPen should be determined by a healthcare professional.